Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Cagrilintide/semaglutide

A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight

Novo Nordisk · Phase 3 · Completed · Enrollment 809

NCT06131437

ArmPopulationDoseWeeksEstimandWeight change
CagriSema 2.4 mg/2.4 mgObesity or overweight2.4 mg16n/rn/r
Tirzepatide 15 mgObesity or overweight15 mg16n/rn/r